Skip to content

Elanco Animal Health Incorporated

ELAN

CIK 0001739104

← back to feed
Revenue (TTM)
$4.94B
+6.2% YoY Q1 May 2026
Net Income (TTM)
$101M
−168.6% YoY Q1 May 2026
EPS Diluted (TTM)
$0.19
−169.1% YoY Q1 May 2026
Gross Margin
56.4%
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
2.0%
Q1 May 2026
Free Cash Flow (TTM)
−$298M
Q1 May 2026
Cash
$428M
Q1 May 2026
Total Debt
$4.4B
Q1 May 2026
Shares Outstanding
499.45M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings